Skip to main content
. 2018 May 2;8(3):137–149. doi: 10.1007/s13659-018-0164-z

Table 2.

Name, source and bioactivities of polycyclic GMs

Number Name Bioactivity Source References
41 Applanatumol V Inhibitory activities against COX-1 and COX-2 G. applanatum [32]
42 Applanatumol W Inhibitory activities against COX-1 and COX-2 G. applanatum [32]
43 Applanatumol X Inhibitory activities against COX-1 and COX-2 G. applanatum [32]
44 Applanatumol Y Inhibitory activities against COX-1 and COX-2 G. applanatum [32]
45 Applanatumol Z Inhibitory activities against COX-1, COX-2 G. applanatum [32]
46 Applanatumol Z2 Inhibitory activities against COX-1, COX-2 G. applanatum [32]
47 Applanatumol K Inhibitory activities against COX-1 and COX-2 G. applanatum [32]
48 Applanatumol L Inhibitory activities against COX-1 and COX-2 G. applanatum [32]
49 Applanatumol M Inhibitory activities against COX-1 and COX-2 G. applanatum [32]
50 Applanatumol N Inhibitory activities against COX-1 and COX-2 G. applanatum [32]
51 Applanatumol O Inhibitory activities against COX-1 and COX-2 G. applanatum [32]
52 Chizhiol A Inhibitory activities against COX-1 and COX-2 G. lucidum [39]
53 Ganotheaecoloid L Inhibitory activities against COX-1 and COX-2 G. theaecolum [40]
54 (+)-Ganotheaecoloid M Inhibitory activities against COX-1 and COX-2 G. theaecolum [40]
55 (−)-Ganotheaecoloid N Inhibitory activities against COX-1 and COX-2 G. theaecoloum [40]
56 Petchiene A Inhibitory activities against COX-1 and COX-2 G. petchii [41]
57 Lingzhine C Promote proliferation of neural stem cells (NSCs) G. lucidum [38]
58 (±)-Lingzhine B Inhibit NSC proliferation G. lucidum [38]
59 (−)-Ganotheaecoloid A Inhibitory activities against COX-2 G. theaecolum [40]
60 (−)-Ganotheaecoloid B Inhibitory activities against COX-2 G. theaecolum [40]
61 Ganotheaecoloid C Inhibitory activities against COX-2 G. theaecolum [40]
62 Ganotheaecoloid D Inhibitory activities against COX-2 G. theaecolum [40]
63 Ganotheaecoloid E Inhibitory activities against COX-2 G. theaecolum [40]
64 (−)-Ganotheaecoloid F Inhibitory activities against COX-2 G. theaecolum [40]
65 Ganotheaecoloid G Inhibitory activities against COX-2 G. theaecolum [40]
66 Ganotheaecoloid H Inhibitory activities against COX-2 G. theaecolum [40]
67 Ganotheaecoloid I Inhibitory activities against COX-2 G. theaecolum [40]
68 (+)-Ganotheaecoloid J COX-2 inhibitory activity (IC50: 9.96 μM) G. theaecolum [40]
69 Ganotheaecoloid K Inhibitory activities against COX-2 G. theaecolum [40]
70 (+)-Cochlearin A Antioxidant activity G. cochlear [30]
71 Spiroapplanatumine A Inhibitory activities against JAK3 kinase G. applanatum [42]
72 Spiroapplanatumine C Inhibitory activities against JAK3 kinase G. applanatum [42]
73 Spiroapplanatumine E Inhibitory activities against JAK3 kinase G. applanatum [42]
74 Spiroapplanatumine G Inhibitory activities against JAK3 kinase G. applanatum [42]
75 Spiroapplanatumine I Inhibitory activities against JAK3 kinase G. applanatum [42]
76 Spiroapplanatumine B Inhibitory activities against JAK3 kinase G. applanatum [42]
77 Spiroapplanatumine D Inhibitory activities against JAK3 kinase (IC50: 7.0 ± 3.2 μM) G. applanatum [42]
78 Spiroapplanatumine F Inhibitory activities against JAK3 kinase (IC50: 34.8 ± 21.1 μM) G. applanatum [42]
79 Spiroapplanatumine H Inhibitory activities against JAK3 kinase G. applanatum [42]
80 Spiroapplanatumine J Inhibitory activities against JAK3 kinase G. applanatum [42]
81 Spiroapplanatumine K Inhibitory activities against JAK3 kinase G. applanatum [42]
82 Spiroapplanatumine L Inhibitory activities against JAK3 kinase G. applanatum [42]
83 Spiroapplanatumine M Inhibitory activities against JAK3 kinase G. applanatum [42]
84 (+)-Spiroapplanatumine N Inhibitory activity against JAK3 kinase G. applanatum [42]
85 Spiroapplanatumine O Inhibitory activities against JAK3 kinase G. applanatum [42]
86 (−)-Spiroapplanatumine N Inhibitory activities against JAK3 kinase G. applanatum [42]
87 Spiroapplanatumine P Inhibitory activities against JAK3 kinase G. applanatum [42]
88 Spiroapplanatumine Q Inhibitory activities against JAK3 kinase G. applanatum [42]
89 (+)- Spirolingzhine A Protective effects for NSC G. lucidum [38]
90 (+)-Spirolingzhine B Protective effects for NSC G. lucidum [38]
91 (+)-Spirolingzhine C Protective effects for NSC G. lucidum [38]
92 Spirolingzhine D Protective effects for NSC G. lucidum [38]
93 (±)-Ganoderin A Antioxidant activity G. cochlear [15]
94 Applanatumol H Inhibitory activities against COX-1, COX-2 G. applanatum [32]
95 Applanatumol I Inhibitory activities against COX-1, COX-2 G. applanatum [32]
96 Applanatumol J Inhibitory activities against COX-1, COX-2 G. applanatum [32]
97 Applanatumol D Inhibitory activities against COX-1, COX-2 G. applanatum [32]
98 Applanatumol E Inhibitory activities against COX-1, COX-2 G. applanatum [32]
99 Applanatumol J Inhibitory activities against COX-1, COX-2 G. applanatum [32]
100 Applanatumol F Inhibitory activities against J COX-1, COX-2 G. applanatum [32]
101 Lingzhilactone A Renoprotective effect G. lucidum [43]
102 Lingzhilactone B Renoprotective effect G. lucidum [43]
103 Lingzhilactone C Renoprotective effect G. lucidum [43]
104 Applanatumol Z3 Inhibitory activities against JAK3 kinase G. applanatum [32]
105 Applanatumol Z4 Inhibitory activities against JAK3 and DDR1 kinases G. applanatum [32]
106 Applanatumol C Inhibitory activities against JAK3 and DDR1 kinases G. applanatum [32]
107 (−)-Lingzhiol Renoprotective effect G. lucidum [44]
108 (±)-Ganocochlearin A Antioxidant activity G. cochlear [15]
109 (±)-Ganocochlearin B Antioxidant activity G. cochlear [15]
110 (±)-Ganocochlearin C Antioxidant activity G. cochlear [15]
111 (±)-Ganocochlearin D Antioxidant activity G. cochlear [15]
112 Lingzhine D Anti-BuChE activity G. lucidum [38]
113 (±)-Ganocin A Anti-BuChE activity G. cochlear [45]
114 (±)-Ganocin B Anti-BuChE activity G. cochlear [45]
115 (±)-Ganocin C Anti-BuChE activity G. cochlear [45]
116 (±)-Ganocin D Anti-BuChE activity G. cochlear [45]
117 Cochlearol A Renoprotective effect G. cochlear [46]
118 Cochlearol B Renoprotective effect G. cochlear [46]
119 Applanatumol A Anti-renal fibrosis G. applanatum [18]
120 (±)-Applanatumol B Anti-renal fibrosis G. applanatum [18]